Clinical Research Strategies proudly endorses the following contract research
organizations (CROs) who have met our strictest embodiment of quality, ethics, deep
experience, and fiscally-sound business practices with key indication experience
in immunoncology, immunotherapy, hematology, cell-based and gene therapies, rare
diseases, CNS, regenerative medicine, surgery, cardiovascular, respiratory, infectious
diseases, rare diseases, device (Class II-III), IVD/LDT/assay, biomarkers, orthopedics,
ophthalmology and more:
Quality & Regulatory Device Experts: https://leanraqa.com/ and
Drug Development: https://www.aydbiopharmaconsultinggroup.com/life-sciences
Clinical Research Strategies CRO qualification criteria: outstanding ethics, financial stability, deep domain know-how and technical experience, and transparency and trust within their internal and external business practices. We review policies, audit/inspection history, interview employees and clients, and request the past 3 years of audit/review financial statements by an independent CPA firm. What influences you to make sound decisions when selecting your CRO partnerships? Ask us how we can help you identify the best partners without overlooking obvious red flags.
CALL FOR CONSULTATION +1.724.272.1245
2019 Copyright © Clinical Research Strategies. All rights reserved.
Founded in 2011.